Jacob B. Frieberg - 10 May 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Jacob Frieberg
Issuer symbol
VCNX
Transactions as of
10 May 2024
Net transactions value
+$8,756
Form type
4
Filing time
14 May 2024, 16:32:24 UTC
Previous filing
25 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 303 10 May 2024 Direct
holding VCNX Common Stock 451 10 May 2024 By Benbow Estates, Ltd. F1
holding VCNX Common Stock 920 10 May 2024 By Gee Eff Services Limited F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $8,756 +2,211 $3.96 2,211 10 May 2024 Common Stock 2,211 $5.75 Direct F9
transaction VCNX Stock Option (Right to Buy) Award $0 +10,108 $0.000000 10,108 10 May 2024 Common Stock 10,108 $5.75 Direct F10
holding VCNX Stock Option (Right to Buy) 30 10 May 2024 Common Stock 30 $2856.00 Direct F3
holding VCNX Stock Option (Right to Buy) 11 10 May 2024 Common Stock 11 $1104.60 Direct F3
holding VCNX Stock Option (Right to Buy) 36 10 May 2024 Common Stock 36 $1633.80 Direct F3, F4
holding VCNX Stock Option (Right to Buy) 11 10 May 2024 Common Stock 11 $1159.20 Direct F3
holding VCNX Stock Option (Right to Buy) 8 10 May 2024 Common Stock 8 $1505.70 Direct F3
holding VCNX Stock Option (Right to Buy) 13 10 May 2024 Common Stock 13 $1018.50 Direct F3
holding VCNX Stock Option (Right to Buy) 15 10 May 2024 Common Stock 15 $840.00 Direct F3
holding VCNX Stock Option (Right to Buy) 74 10 May 2024 Common Stock 74 $829.50 Direct F3, F5
holding VCNX Stock Option (Right to Buy) 17 10 May 2024 Common Stock 17 $758.10 Direct F3
holding VCNX Stock Option (Right to Buy) 36 10 May 2024 Common Stock 36 $373.80 Direct F3
holding VCNX Stock Option (Right to Buy) 31 10 May 2024 Common Stock 31 $434.70 Direct F3
holding VCNX Stock Option (Right to Buy) 21 10 May 2024 Common Stock 21 $625.80 Direct F3
holding VCNX Stock Option (Right to Buy) 136 10 May 2024 Common Stock 136 $451.50 Direct F3, F6
holding VCNX Stock Option (Right to Buy) 22 10 May 2024 Common Stock 22 $588.00 Direct F3
holding VCNX Stock Option (Right to Buy) 29 10 May 2024 Common Stock 29 $453.60 Direct F3
holding VCNX Stock Option (Right to Buy) 61 10 May 2024 Common Stock 61 $218.40 Direct F3
holding VCNX Stock Option (Right to Buy) 47 10 May 2024 Common Stock 47 $277.20 Direct F3
holding VCNX Stock Option (Right to Buy) 253 10 May 2024 Common Stock 253 $235.20 Direct F3, F7
holding VCNX Stock Option (Right to Buy) 57 10 May 2024 Common Stock 57 $226.80 Direct F3
holding VCNX Stock Option (Right to Buy) 125 10 May 2024 Common Stock 125 $104.02 Direct F3
holding VCNX Stock Option (Right to Buy) 94 10 May 2024 Common Stock 94 $135.52 Direct F3
holding VCNX Stock Option (Right to Buy) 152 10 May 2024 Common Stock 152 $83.86 Direct F3
holding VCNX Stock Option (Right to Buy) 684 10 May 2024 Common Stock 684 $86.10 Direct F3, F8
holding VCNX Stock Option (Right to Buy) 172 10 May 2024 Common Stock 172 $74.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
F3 Exercisable in full as of the date of this report.
F4 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F6 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F7 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F8 This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F9 Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2024. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
F10 This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first.

Remarks:

On February 19, 2024, Vaccinex, Inc. effected a 1-for-14 reverse stock split (the "Reverse Stock Split"). The number of stock options and underlying shares of common stock in this Form 4 reflect the Reverse Stock Split.